HRP20090190T1 - Pharmaceutical composition comprising a salt of mirtazapine - Google Patents
Pharmaceutical composition comprising a salt of mirtazapineInfo
- Publication number
- HRP20090190T1 HRP20090190T1 HR20090190T HRP20090190T HRP20090190T1 HR P20090190 T1 HRP20090190 T1 HR P20090190T1 HR 20090190 T HR20090190 T HR 20090190T HR P20090190 T HRP20090190 T HR P20090190T HR P20090190 T1 HRP20090190 T1 HR P20090190T1
- Authority
- HR
- Croatia
- Prior art keywords
- salt
- mirtazapine
- pharmaceutical composition
- acid salt
- subliming
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04101664 | 2004-04-21 | ||
| PCT/EP2005/051714 WO2005102352A1 (en) | 2004-04-21 | 2005-04-19 | Pharmaceutical composition comprising a salt of mirtazapine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20090190T1 true HRP20090190T1 (en) | 2009-05-31 |
Family
ID=34928990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20090190T HRP20090190T1 (en) | 2004-04-21 | 2005-04-19 | Pharmaceutical composition comprising a salt of mirtazapine |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US20070111993A1 (enExample) |
| EP (1) | EP1729777B1 (enExample) |
| JP (2) | JP5260959B2 (enExample) |
| CN (2) | CN1942191B (enExample) |
| AR (1) | AR049028A1 (enExample) |
| AT (1) | ATE424210T1 (enExample) |
| AU (1) | AU2005235383B2 (enExample) |
| BR (1) | BRPI0509953A (enExample) |
| CA (1) | CA2561281C (enExample) |
| CY (1) | CY1109018T1 (enExample) |
| DE (1) | DE602005013066D1 (enExample) |
| DK (1) | DK1729777T3 (enExample) |
| EC (1) | ECSP066938A (enExample) |
| ES (1) | ES2321961T3 (enExample) |
| HR (1) | HRP20090190T1 (enExample) |
| IL (1) | IL178201A (enExample) |
| LV (1) | LV13556B (enExample) |
| MX (1) | MXPA06011830A (enExample) |
| MY (1) | MY144899A (enExample) |
| NO (1) | NO20065077L (enExample) |
| NZ (1) | NZ550052A (enExample) |
| PE (1) | PE20060400A1 (enExample) |
| PL (1) | PL1729777T3 (enExample) |
| PT (1) | PT1729777E (enExample) |
| RS (1) | RS50764B (enExample) |
| RU (1) | RU2375362C2 (enExample) |
| SI (1) | SI1729777T1 (enExample) |
| TW (1) | TW200538100A (enExample) |
| UA (1) | UA89773C2 (enExample) |
| WO (1) | WO2005102352A1 (enExample) |
| ZA (1) | ZA200608305B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA83666C2 (ru) * | 2003-07-10 | 2008-08-11 | Н.В. Органон | Способ получения энантиомерно чистого миртазапина |
| EP1792618A1 (en) * | 2005-11-30 | 2007-06-06 | Rainer Freynhagen | R-mirtazapine for the treatment of pain |
| TW200808804A (en) * | 2006-05-22 | 2008-02-16 | Organon Nv | Mirtazapine for the treatment of neuropathic pain |
| CN104095824B (zh) * | 2013-04-09 | 2016-08-31 | 上海信谊万象药业股份有限公司 | 一种米氮平缓释片及其制备方法 |
| JP6876003B2 (ja) | 2015-02-27 | 2021-05-26 | デクラ リミテッド | イヌ及びネコにおける、食欲の刺激、体重減少の管理、及び拒食症の処置 |
| CN111053735A (zh) * | 2020-02-25 | 2020-04-24 | 上海阶平医院管理有限公司 | 一种治疗失眠的冷敷凝胶 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
| US4193828A (en) * | 1976-07-27 | 1980-03-18 | Fiber Materials, Inc. | Method of forming carbon composites |
| US4515792A (en) * | 1982-09-30 | 1985-05-07 | Ciba-Geigy Corporation | Tetracyclic heterocycles and antidepressant compositions thereof |
| IL121076A (en) * | 1996-06-19 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
| EP0813873B1 (en) * | 1996-06-19 | 2002-02-13 | Akzo Nobel N.V. | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
| ES2212550T3 (es) * | 1998-04-02 | 2004-07-16 | Akzo Nobel N.V. | Solucion oral liquida que comprende el antidepresor mirtazapina. |
| WO2001000196A2 (en) * | 1999-06-25 | 2001-01-04 | University Of South Florida | Mirtazapine for weight gain in wasting diseases |
| US6281207B1 (en) * | 1999-09-15 | 2001-08-28 | Reed Richter | Treatment of movement disorders by administration of mirtazapine |
| WO2001042239A1 (en) * | 1999-12-13 | 2001-06-14 | Sumika Fine Chemicals Co., Ltd. | Process for the preparation of a pyridinemethanol compound |
| HK1047547B (en) * | 2000-04-05 | 2003-10-10 | Akzo Nobel N.V. | Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug |
-
2005
- 2005-04-12 TW TW094111559A patent/TW200538100A/zh unknown
- 2005-04-19 BR BRPI0509953-6A patent/BRPI0509953A/pt not_active IP Right Cessation
- 2005-04-19 RS RSP-2009/0164A patent/RS50764B/sr unknown
- 2005-04-19 WO PCT/EP2005/051714 patent/WO2005102352A1/en not_active Ceased
- 2005-04-19 UA UAA200610312A patent/UA89773C2/ru unknown
- 2005-04-19 EP EP05740221A patent/EP1729777B1/en not_active Expired - Lifetime
- 2005-04-19 CN CN2005800116628A patent/CN1942191B/zh not_active Expired - Fee Related
- 2005-04-19 DE DE602005013066T patent/DE602005013066D1/de not_active Expired - Lifetime
- 2005-04-19 PT PT05740221T patent/PT1729777E/pt unknown
- 2005-04-19 NZ NZ550052A patent/NZ550052A/en unknown
- 2005-04-19 CA CA2561281A patent/CA2561281C/en not_active Expired - Fee Related
- 2005-04-19 HR HR20090190T patent/HRP20090190T1/xx unknown
- 2005-04-19 PL PL05740221T patent/PL1729777T3/pl unknown
- 2005-04-19 RU RU2006140988/04A patent/RU2375362C2/ru not_active IP Right Cessation
- 2005-04-19 ES ES05740221T patent/ES2321961T3/es not_active Expired - Lifetime
- 2005-04-19 US US11/547,152 patent/US20070111993A1/en not_active Abandoned
- 2005-04-19 MX MXPA06011830A patent/MXPA06011830A/es not_active IP Right Cessation
- 2005-04-19 SI SI200530673T patent/SI1729777T1/sl unknown
- 2005-04-19 AT AT05740221T patent/ATE424210T1/de active
- 2005-04-19 MY MYPI20051731A patent/MY144899A/en unknown
- 2005-04-19 CN CN201010174000A patent/CN101824035A/zh active Pending
- 2005-04-19 JP JP2007508904A patent/JP5260959B2/ja not_active Expired - Fee Related
- 2005-04-19 AU AU2005235383A patent/AU2005235383B2/en not_active Expired
- 2005-04-19 DK DK05740221T patent/DK1729777T3/da active
- 2005-04-20 AR ARP050101549A patent/AR049028A1/es unknown
- 2005-04-20 PE PE2005000439A patent/PE20060400A1/es not_active Application Discontinuation
-
2006
- 2006-09-20 IL IL178201A patent/IL178201A/en not_active IP Right Cessation
- 2006-10-05 ZA ZA200608305A patent/ZA200608305B/xx unknown
- 2006-10-19 EC EC2006006938A patent/ECSP066938A/es unknown
- 2006-11-03 NO NO20065077A patent/NO20065077L/no not_active Application Discontinuation
- 2006-11-21 LV LVP-06-130A patent/LV13556B/lv unknown
-
2009
- 2009-05-05 CY CY20091100481T patent/CY1109018T1/el unknown
-
2013
- 2013-03-08 JP JP2013046645A patent/JP2013136626A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20080640T3 (en) | Aqueous pharmaceutical preparation comprising roflumilast | |
| CY1120138T1 (el) | Στερεη φαρμακευτικη μορφη δοσολογιας που περιλαμβανει μια στερεη διασπορα αναστολεα πρωτεασης toy hiv | |
| WO2004062577A3 (en) | Two or more enteric materials to regulate drug release | |
| DK1299348T3 (da) | Forbindelser og sammensætninger til levering af aktive midler | |
| HRP20020158B1 (en) | Action of synergistic combination | |
| DE60124587D1 (de) | 2-butyl-3-(4-3(dibutylamino)propoxyü benzoyl)-5-nitrobenzofuran-hydrochlorid und dessen herstellung | |
| HRP20060240T3 (hr) | Intranazalni pripravak rotigotina | |
| EE04911B1 (et) | Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks | |
| MEP33708A (hr) | Farmaceutske smješe koje obuhvataju inhibitor hmg coa reduktaze | |
| MY142444A (en) | Chemokine receptor antagonists | |
| TW200635897A (en) | Piperidine derivatives and their use as anti-inflammatory agents | |
| ITMI20011337A0 (it) | Composizioni farmaceutiche orali a rilascio modificato del principio attivo | |
| EP1233956A4 (en) | BRYOSTATIN ANALOGUES, METHODS OF SYNTHESIS AND USES | |
| WO2005103037A3 (de) | Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
| ATE399171T1 (de) | Camptothecinanaloge und deren zubereitungsmethoden | |
| UA90518C2 (ru) | Фармацевтическая композиция в форме таблетки, которая имеет улучшеное всасывание при трансбукальном введение, которая содержит наркотический активный ингредиент и амин | |
| BR0114903A (pt) | 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação | |
| WO2006000371A3 (en) | Pyrimidine derivatives as 11beta-hsd1 inhibitors | |
| ATE454385T1 (de) | Hiv-integrase-hemmers, pharmazeutischen zusammensetzung und ihre anwendung | |
| WO2001068645A3 (en) | N-cyanomethylcarboxamides and their use as protease inhibitors | |
| WO2005026145A3 (en) | Quinolone antibacterial agents | |
| WO2003101996A3 (en) | Esters in position 20 of camptothecins | |
| SE0001916D0 (sv) | Novel formulation | |
| HRP20020989B1 (hr) | Enantiomer 1,2-aneliranog kinolina koji inhibira farnezil transferazu | |
| ES2192789T3 (es) | Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios. |